Related Experiment Video
Updated: Oct 5, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Basket Designs: Statistical Considerations for Oncology Trials
Alexander M Kaizer1, Joseph S Koopmeiners2, Michael J Kane3
1University of Colorado Anschutz Medical Campus, Aurora, CO.
Abstract:
Progress in the areas of genomics, disease pathways, and drug discovery has advanced into clinical and translational cancer research. The latest innovations in clinical trials have followed with master protocols, which are defined by inclusive eligibility criteria and devised to interrogate multiple therapies for a given tumor histology and/or multiple histologies for a given therapy under one protocol. The use of master protocols for oncology has become more common with the desire to improve the efficiency of clinical research and accelerate overall drug development. Basket trials have been devised to ascertain the extent to which a treatment strategy offers benefit to various patient subpopulations defined by a common molecular target. Conventionally conducted within the phase II setting, basket designs have become popular as drug developers seek to effectively evaluate and identify preliminary efficacy signals among clinical indications identified as promising in preclinical study. This article reviews basket trial designs in oncology settings and discusses several issues that arise with their design and analysis.
Insights
Master protocols, including basket trials, enhance oncology clinical research efficiency. These innovative designs accelerate drug development by evaluating multiple therapies across various patient subgroups with common molecular targets.
Area of Science:
- Oncology
- Clinical Research
- Genomics
Background:
- Genomic advancements and drug discovery have propelled translational cancer research.
- Master protocols, featuring inclusive criteria, are increasingly used in oncology clinical trials.
- These protocols efficiently test multiple therapies for specific tumor types or across histologies.
Purpose of the Study:
- To review basket trial designs in oncology.
- To discuss challenges in the design and analysis of basket trials.
Main Methods:
- Basket trials evaluate treatment efficacy in patient subpopulations with a shared molecular target.
- These trials are commonly conducted in the phase II setting.
- They aim to identify preliminary efficacy signals for promising preclinical indications.
Main Results:
- Basket trials facilitate the evaluation of targeted therapies across diverse cancer types.
- They offer a structured approach to identifying potential drug benefits in specific molecularly defined groups.
- The article reviews design considerations and analytical issues pertinent to basket trials.
Conclusions:
- Basket trials represent a key innovation in oncology clinical research, improving efficiency.
- Their design allows for the investigation of targeted therapies in molecularly selected patient groups.
- Addressing design and analysis challenges is crucial for maximizing the utility of basket trials.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Clinical Trials
There are four phases in a clinical trial. A phase one...

